Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Clara Hjalmarsson, Barbro Kjellström, Kjell Jansson, Magnus Nisell, David Kylhammar, Mohammad Kavianipour, Göran Rådegran, Stefan Söderberg, Gerhard Wikström, Dirk M. Wuttge, Roger Hesselstrand. Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment. ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020

Member's Comments

No comment yet.

Related content which might interest you: Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience Year: 2008 Distance assessment of the risk of pulmonary hypertension associated with connective tissue diseases: do biomarkers help? Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018 Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment Source: Eur Respir Rev 2014; 23: 505-509 Year: 2014 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Application of a formula to predict mean pulmonary artery pressures in patients with connective tissue disease Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018 Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1602493; 10.1183/13993003.02493-2016 Year: 2017 Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1800467; 10.1183/13993003.00467-2018 Year: 2018 Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018 Year: 2018